Literature DB >> 11955455

Clinical significance and pathogenesis of viral respiratory infections.

Jack M Gwaltney1.   

Abstract

Viral respiratory tract infections, also known as colds, are the most common infection in humans. The majority of these infections are caused by rhinoviruses. Rhinovirus deposition in the nose or the eye initiates infection. The virus attaches to the host cell intercellular adhesion molecule-1 (ICAM-1) receptors in the back of the throat. Subsequent viral replication triggers the release of inflammatory mediators and activation of neurogenic pathways, which lead to symptoms. Symptoms occur within 10 to 16 hours after virus entry into the nose and peak on days 2 to 3 of infection. Symptom duration is typically 1 week, although 25% of cases last longer. Understanding the chronology of these events is important in the timing of treatment. Because of the rapidity of symptom onset, early treatment is the key to reducing viral replication and illness. Also, early treatment may reduce the risk of transmission.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11955455     DOI: 10.1016/s0002-9343(01)01059-2

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  30 in total

Review 1.  Significance of fomites in the spread of respiratory and enteric viral disease.

Authors:  Stephanie A Boone; Charles P Gerba
Journal:  Appl Environ Microbiol       Date:  2007-01-12       Impact factor: 4.792

2.  Effects of creating a non-specific, virus-hostile environment in the nasopharynx on symptoms and duration of common cold.

Authors:  D Hull; P Rennie; A Noronha; C Poore; N Harrington; V Fearnley; D Passàli
Journal:  Acta Otorhinolaryngol Ital       Date:  2007-04       Impact factor: 2.124

Review 3.  Dysfunctional nucleus tractus solitarius: its crucial role in promoting neuropathogenetic cascade of Alzheimer's dementia--a novel hypothesis.

Authors:  Mak Adam Daulatzai
Journal:  Neurochem Res       Date:  2012-01-05       Impact factor: 3.996

4.  Efficacy of an extract of North American ginseng containing poly-furanosyl-pyranosyl-saccharides for preventing upper respiratory tract infections: a randomized controlled trial.

Authors:  Gerald N Predy; Vinti Goel; Ray Lovlin; Allan Donner; Larry Stitt; Tapan K Basu
Journal:  CMAJ       Date:  2005-10-25       Impact factor: 8.262

5.  FluSense: A Contactless Syndromic Surveillance Platform for Influenza-Like Illness in Hospital Waiting Areas.

Authors:  Forsad Al Hossain; Andrew A Lover; George A Corey; Nicholas G Reich; Tauhidur Rahman
Journal:  Proc ACM Interact Mob Wearable Ubiquitous Technol       Date:  2020-03-18

Review 6.  Probiotics for preventing acute upper respiratory tract infections.

Authors:  Yunli Zhao; Bi Rong Dong; Qiukui Hao
Journal:  Cochrane Database Syst Rev       Date:  2022-08-24

7.  Pathophysiology of nasal congestion.

Authors:  Robert M Naclerio; Claus Bachert; James N Baraniuk
Journal:  Int J Gen Med       Date:  2010-04-08

Review 8.  Ocular tropism of respiratory viruses.

Authors:  Jessica A Belser; Paul A Rota; Terrence M Tumpey
Journal:  Microbiol Mol Biol Rev       Date:  2013-03       Impact factor: 11.056

9.  Human rhinovirus type 16: mutant V1210A requires capsid-binding drug for assembly of pentamers to form virions during morphogenesis.

Authors:  Wai-Ming Lee; Wensheng Wang
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

Review 10.  Applications of the phytomedicine Echinacea purpurea (Purple Coneflower) in infectious diseases.

Authors:  James B Hudson
Journal:  J Biomed Biotechnol       Date:  2011-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.